Pattern of Recurrence of Completely Resected Lung Adenocarcinoma Varies According to EGFR Mutation Status

被引：0

作者：

Watanabe, K. ^{[1
]}

Sakamaki, K. ^{[2
]}

Ito, H. ^{[3
]}

Yokose, T. ^{[4
]}

Yamada, K. ^{[5
]}

Nakayama, H. ^{[3
]}

Masuda, M. ^{[6
]}

机构：

[1] Yokohama Med Ctr, Gen Thorac Surg, Yokohama, Kanagawa, Japan

[2] Univ Tokyo, Biostat & Bioinformat, Tokyo, Japan

[3] Kanagawa Canc Ctr, Dept Thorac Surg, Yokohama, Kanagawa, Japan

[4] Kanagawa Canc Ctr, Pathol, Yokohama, Kanagawa, Japan

[5] Kanagawa Canc Ctr, Thorac Oncol, Yokohama, Kanagawa, Japan

[6] Yokohama City Univ, Yokohama, Kanagawa, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

关键词：

EGFR; Surgery; recurrence dynamics;

D O I：

10.1016/j.jtho.2018.08.1918

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.16-11

引用

页码：S1007 / S1007

页数：1

共 50 条

[21] The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma
Mizutani, Kenichi
Guo, Xin
Shioya, Akihiro
Zhang, Jing
Zheng, Jianbo
Kurose, Nozomu
Ishibashi, Hiroaki
Motono, Nozomu
Uramoto, Hidetaka
Yamada, Sohsuke
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (09): : 1199 - 1206
[22] Study of the Relationship between EGFR Mutation Status and Bone Metastasis in Advanced Lung Adenocarcinoma
Bing, Z.
Xiaoye, A.
Yasheng, A.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2201 - S2201
[23] Effect of platinum-based chemotherapy on EGFR gene mutation status in lung adenocarcinoma
Wang, Yuli
Ma, Xinyu
Wei, Yuan
Ma, Di
Gong, Ping
MEDICINE, 2018, 97 (04)
[24] THE IMPACT OF EGFR MUTATION STATUS ON CLINICAL OUTCOMES IN PATIENTS WITH LOCALLY ADVANCED LUNG ADENOCARCINOMA
Akamatsu, Hiroaki
Murakami, Haruyasu
Ono, Akira
Shukuya, Takehito
Tsuya, Asuka
Nakamura, Yukiko
Naito, Tateaki
Kenmotsu, Hirotsugu
Takahashi, Toshiaki
Endo, Masahiro
Harada, Hideyuki
Nakajima, Takashi
Yamamoto, Nobuyuki
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1547 - S1547
[25] Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma
Ito, Masaoki
Miyata, Yoshihiro
Kushitani, Kei
Yoshiya, Tomoharu
Kai, Yuichiro
Tsutani, Yasuhiro
Mimura, Takeshi
Konishi, Kazuo
Takeshima, Yukio
Okada, Morihito
THORACIC CANCER, 2018, 9 (12) : 1594 - 1602
[26] Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
Marks, Jenifer L.
Broderick, Stephen
Zhou, Qin
Chitale, Dhananjay
Li, Allan R.
Zakowski, Maureen F.
Kris, Mark G.
Rusch, Valerie W.
Azzoli, Christopher G.
Seshan, Venkatraman E.
Ladanyi, Marc
Pao, William
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 111 - 116
[27] Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification
Dong, Yu-Jie
Cai, Yi-Ran
Zhou, Li-Juan
Su, Dan
Mu, Jing
Chen, Xue-Jing
Zhang, Li
ONCOLOGY LETTERS, 2016, 11 (04) : 2552 - 2558
[28] The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma
Zhou, Wensheng
Liu, Zhichao
Wang, Yanan
Zhang, Yanwei
Qian, Fangfei
Lu, Jun
Wang, Huimin
Gu, Ping
Hu, Minjuan
Chen, Ya
Yang, Zhengyu
Zhao, Ruiying
Lou, Yuqing
Han, Baohui
Zhang, Wei
CANCER MEDICINE, 2022, 11 (05): : 1299 - 1309
[29] THE PROGNOSTIC ROLE OF EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION IN COMPLETELY RESECTED AMPULLARY ADENOCARCINOMA
Varol, Umut
Cakir, Ebru
Aktas, Safiye
Altun, Zekiye Sultan
Dilek, Fatma Husniye
Butun, Osman
Salman, Tarik
Unlu, Ause Gulden Diniz
Aiacaciogiu, Ahmet
Somall, Isil
POLISH JOURNAL OF PATHOLOGY, 2023, 74 (01) : 18 - 28
[30] Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma
Wang, Zeng
Yang, Shifeng
Lu, Hongyang
ONCOTARGETS AND THERAPY, 2017, 10 : 3345 - 3351

← 1 2 3 4 5 →